Citadel Advisors’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.74M Buy
241,000
+65,900
+38% +$2.42M ﹤0.01% 3631
2025
Q4
$6.72M Buy
175,100
+98,200
+128% +$2.15M ﹤0.01% 3837
2025
Q3
$1.06M Buy
76,900
+30,000
+64% +$352K ﹤0.01% 7424
2025
Q2
$606K Sell
46,900
-54,100
-54% -$562K ﹤0.01% 8176
2025
Q1
$1.14M Buy
101,000
+26,600
+36% +$349K ﹤0.01% 6689
2024
Q4
$975K Buy
74,400
+69,200
+1,331% +$1.78M ﹤0.01% 7079
2024
Q3
$208K Buy
5,200
+2,200
+73% +$80K ﹤0.01% 10065
2024
Q2
$88.5K Buy
+3,000
New +$81.7K ﹤0.01% 11087

Other funds holding PACS

Citadel Advisors's PACS Position: Q1 2026 in Review

Citadel Advisors increased its PACS Group (PACS) stake by 37% in Q1 2026, buying an estimated $6.11M and bringing the position to 614,814 shares worth $19.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Citadel Advisors first reported a position in PACS in Q2 2024 and has held it in 8 quarters since. The position peaked at $25.2M in Q2 2024. 215 funds tracked by Wall St. Rank hold PACS as of Q1 2026.

  • Citadel Advisors held 614,814 shares of PACS Group worth $19.7M as of Q1 2026.
  • Citadel Advisors bought 166,114 PACS Group shares in Q1 2026, an estimated $6.11M.
  • PACS Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2360 holding.
  • Citadel Advisors first reported a position in PACS Group in Q2 2024 and has held it in 8 quarters since.
  • Citadel Advisors's PACS Group position peaked at $25.2M in Q2 2024.
  • 215 funds tracked by Wall St. Rank held PACS Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.